ResearcherPhilipps University of MarburgActive in the last 2 years
Veronika Lutz
Matched on ORCID iD 0000-0002-3139-0916; OpenAlex author ID A5028766257. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 20
2023: 2 papers · 2024: 2 papers
Papers 4
- DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer. Co-author DOI 10.1136/gutjnl-2023-331854↗
- Optimized Spheroid Model of Pancreatic Cancer Demonstrates Influence of Macrophage-T Cell Interaction for Intratumoral T Cell Motility. Co-author DOI 10.3390/cancers17010051↗
- IL-17A-producing CD8+ T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts. First author DOI 10.1136/gutjnl-2022-327855↗
- IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer Model. Co-author DOI 10.1158/2326-6066.cir-22-0398↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Magdalena Huber · 4 shared papers, 2023–2024 · strength 0.65
- Paper Optimized Spheroid Model of Pancreatic Cancer Demonstrates Influence of Macrophage-T Cell Interaction for Intratumoral … DOI 10.3390/cancers17010051↗
- Paper DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer. DOI 10.1136/gutjnl-2023-331854↗
- Paper IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in… DOI 10.1158/2326-6066.cir-22-0398↗
- Thomas Mathias Gress · 4 shared papers, 2023–2024 · strength 0.65
- Paper Optimized Spheroid Model of Pancreatic Cancer Demonstrates Influence of Macrophage-T Cell Interaction for Intratumoral … DOI 10.3390/cancers17010051↗
- Paper DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer. DOI 10.1136/gutjnl-2023-331854↗
- Paper IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in… DOI 10.1158/2326-6066.cir-22-0398↗
- Malte Buchholz · 3 shared papers, 2023–2024 · strength 0.49
- Paper Optimized Spheroid Model of Pancreatic Cancer Demonstrates Influence of Macrophage-T Cell Interaction for Intratumoral … DOI 10.3390/cancers17010051↗
- Paper IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in… DOI 10.1158/2326-6066.cir-22-0398↗
- Paper IL-17A-producing CD8+ T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts. DOI 10.1136/gutjnl-2022-327855↗
- Christian Alexander Bauer · 3 shared papers, 2023–2024 · strength 0.49
- Paper Optimized Spheroid Model of Pancreatic Cancer Demonstrates Influence of Macrophage-T Cell Interaction for Intratumoral … DOI 10.3390/cancers17010051↗
- Paper IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in… DOI 10.1158/2326-6066.cir-22-0398↗
- Paper IL-17A-producing CD8+ T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts. DOI 10.1136/gutjnl-2022-327855↗
- Felix S.R. Picard · 3 shared papers, 2023–2024 · strength 0.44
- Paper DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer. DOI 10.1136/gutjnl-2023-331854↗
- Paper IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in… DOI 10.1158/2326-6066.cir-22-0398↗
- Paper IL-17A-producing CD8+ T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts. DOI 10.1136/gutjnl-2022-327855↗
- Corinna Ulrike Keber · 2 shared papers, 2023–2024 · strength 0.31
- Anna I. Brichkina · 2 shared papers, 2023–2024 · strength 0.29
- Detlef Klaus Bartsch · 2 shared papers, 2023–2024 · strength 0.29
- Matthias Lauth · 2 shared papers, 2023–2024 · strength 0.29
- Elena Nasiri · 1 shared paper, 2024 · strength 0.22
- Vanessa Zimmer · 1 shared paper, 2024 · strength 0.22
- Benedikt Slusny · 1 shared paper, 2024 · strength 0.22
- Carsten Denkert · 1 shared paper, 2024 · strength 0.16
- Peter Duewell · 1 shared paper, 2023 · strength 0.15
- Shiv K. Singh · 1 shared paper, 2023 · strength 0.12
- Matthias M. Gaida · 1 shared paper, 2023 · strength 0.12
- Philipp Mayer · 1 shared paper, 2023 · strength 0.12
- Lukas Klein · 1 shared paper, 2023 · strength 0.12
- Mengyu Tu · 1 shared paper, 2023 · strength 0.12
- Robert Liefke · 1 shared paper, 2023 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.